The new GLP-1 RA users, SGLT-2 inhibitor users and DPP-4 inhibitor users were defined as a first-time redemption for prescription of drugs with anatomical therapeutic chemical (ATC) codes A10BJ (GLP-1), A10BH (DPP-4 inhibitors) or A10BK (SGLT-2 inhibitors)
doi.org/10.1038/newbio243085a0 Pickart, L., et al
GLP-1s like semaglutide and tirzepatide are FDA-approved for weight loss and diabetes, so these are the safest bet legally
Elevated plasma vitamin B12 levels as a marker for cancer: a population-based cohort study
Adding a second peptide without understanding how the mechanisms overlap or compound side effects is how people end up with an intolerable protocol they can't troubleshoot
TrimRx includes medication, clinician access, dose titration support, and shipping